1-5 of 5
Brenda M. Sandmaier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors

Available to Purchase
Johnnie J. Orozco, Phuong T. Vo, Ted A. Gooley, Robyn L. Haaf, Sally J. Lundberg, Donald K. Hamlin, D. Scott Wilbur, Manuela C. Matesan, Darrell R. Fisher, Ajay K. Gopal, Damian J. Green, John M. Pagel, Brenda M. Sandmaier
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 274–282.
https://doi.org/10.1158/1078-0432.CCR-23-1200
Published: 17 January 2024
View articletitled, Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors
Open the PDF for Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors in another window
Includes: Supplementary data
Journal Articles

Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma

Free
Ryan D. Cassaday, Oliver W. Press, John M. Pagel, Joseph G. Rajendran, Ted A. Gooley, Darrell R. Fisher, Leona A. Holmberg, Robert S. Miyaoka, Brenda M. Sandmaier, Damian J. Green, Ajay K. Gopal
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 6932–6938.
https://doi.org/10.1158/1078-0432.CCR-19-1567
Published: 02 December 2019
View articletitled, Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma
Open the PDF for Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma in another window
Includes: Supplementary data
Journal Articles

A Limited Sampling Schedule to Estimate Individual Pharmacokinetic Parameters of Fludarabine in Hematopoietic Cell Transplant Patients

Free
David H. Salinger, David K. Blough, Paolo Vicini, Claudio Anasetti, Paul V. O'Donnell, Brenda M. Sandmaier, Jeannine S. McCune
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5280–5287.
https://doi.org/10.1158/1078-0432.CCR-09-0427
Published: 12 August 2009
View articletitled, A Limited Sampling Schedule to Estimate Individual Pharmacokinetic Parameters of Fludarabine in Hematopoietic Cell Transplant Patients
Open the PDF for A Limited Sampling Schedule to Estimate Individual Pharmacokinetic Parameters of Fludarabine in Hematopoietic Cell Transplant Patients in another window
Journal Articles

C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients

Free
Scott S. Tykodi, Nobuharu Fujii, Nathalie Vigneron, Sharon M. Lu, Jeffrey K. Mito, Maureen X. Miranda, Jeffrey Chou, Lilien N. Voong, John A. Thompson, Brenda M. Sandmaier, Peter Cresswell, Benoît Van den Eynde, Stanley R. Riddell, Edus H. Warren
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5260–5269.
https://doi.org/10.1158/1078-0432.CCR-08-0028
Published: 12 August 2008
View articletitled, C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients
Open the PDF for C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients in another window
Includes: Supplementary data
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning: Toxicity, Clinical Response, and Immunological Response to Minor Histocompatibility Antigens

Free
Scott S. Tykodi, Edus H. Warren, John A. Thompson, Stanley R. Riddell, Richard W. Childs, Brith E. Otterud, Mark F. Leppert, Rainer Storb, Brenda M. Sandmaier
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 7799–7811.
https://doi.org/10.1158/1078-0432.CCR-04-0072
Published: 07 December 2004
View articletitled, Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning: Toxicity, Clinical Response, and Immunological Response to Minor Histocompatibility Antigens
Open the PDF for Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning: Toxicity, Clinical Response, and Immunological Response to Minor Histocompatibility Antigens in another window